,Set,NGenes,Direction,PValue,FDR
1,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Down,0.000952914115287022,0.409295850069515
2,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Up,0.00198773390811135,0.409295850069515
3,WP_ESTROGEN_METABOLISM_WP697,5,Up,0.00257243943538891,0.409295850069515
4,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Down,0.00303726144359515,0.409295850069515
5,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,14,Down,0.00364850896442292,0.409295850069515
6,WP_IRON_METABOLISM_DISORDERS,10,Up,0.00448699625945654,0.409295850069515
7,WP_HEDGEHOG_SIGNALING_WP47,6,Up,0.00609777178908774,0.409295850069515
8,WP_GABA_RECEPTOR_SIGNALING,10,Up,0.00740585863540308,0.409295850069515
9,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,46,Up,0.00752826056946717,0.409295850069515
10,WP_ZINC_HOMEOSTASIS,21,Up,0.00774623681498477,0.409295850069515
11,WP_BENZENE_METABOLISM,3,Up,0.0082330933689019,0.409295850069515
12,WP_VITAMIN_B12_METABOLISM,22,Up,0.00848539847759549,0.409295850069515
13,WP_INTEGRATED_CANCER_PATHWAY,40,Up,0.008688189671495,0.409295850069515
14,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Up,0.00871902231722948,0.409295850069515
15,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Up,0.00913348441081456,0.409295850069515
16,WP_INFLAMMATORY_RESPONSE_PATHWAY,13,Up,0.00929373659811595,0.409295850069515
17,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Up,0.0100563088351105,0.409295850069515
18,WP_LIVER_X_RECEPTOR_PATHWAY,5,Up,0.0100919980914999,0.409295850069515
19,WP_SMALL_CELL_LUNG_CANCER,68,Up,0.0109327302523627,0.409295850069515
20,WP_OXIDATIVE_STRESS_RESPONSE,21,Up,0.0115090293607927,0.409295850069515
21,WP_FERROPTOSIS,50,Up,0.0115763028114011,0.409295850069515
22,WP_SULFATASE_AND_AROMATASE_PATHWAY,2,Up,0.0116259846445806,0.409295850069515
23,WP_GDNFRET_SIGNALING_AXIS,4,Up,0.0119532844697801,0.409295850069515
24,WP_DNA_DAMAGE_RESPONSE,58,Up,0.012169890959875,0.409295850069515
25,WP_DOPAMINE_METABOLISM,7,Up,0.0124481706225522,0.409295850069515
26,WP_FATTY_ACID_TRANSPORTERS,10,Up,0.0137008311753837,0.433157047160207
27,WP_OXIDATIVE_PHOSPHORYLATION,50,Up,0.0142621122726122,0.434202084743972
28,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,19,Up,0.0160394564109166,0.470872613206195
29,WP_IRON_METABOLISM_IN_PLACENTA,8,Up,0.0180029869032281,0.510291559808741
30,WP_SELENIUM_MICRONUTRIENT_NETWORK,48,Up,0.0194617230429915,0.517475805549291
31,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,5,Down,0.0197695620356927,0.517475805549291
32,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,20,Up,0.0201450435250332,0.517475805549291
33,WP_NEPHROGENESIS,4,Down,0.0215993591915231,0.518483822957842
34,WP_GENES_CONTROLLING_NEPHROGENESIS,13,Up,0.0218317412362434,0.518483822957842
35,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Down,0.0220765618047743,0.518483822957842
36,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.0240953883169775,0.550178033237653
37,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Up,0.0249117475101519,0.553444769009321
38,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,128,Up,0.0256340428978732,0.554504822685573
39,WP_GPCRS_OTHER,10,Down,0.0277136232451215,0.584077663433208
40,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,39,Down,0.0284222707266768,0.584077663433208
41,WP_COMPLEMENT_ACTIVATION,12,Up,0.0309033693375784,0.586004754408197
42,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,59,Up,0.03158452873495,0.586004754408197
43,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,17,Down,0.0318870939725842,0.586004754408197
44,WP_FOLATE_METABOLISM,35,Up,0.0328309817165179,0.586004754408197
45,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,9,Up,0.0333019297788876,0.586004754408197
46,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,73,Up,0.0352903627053812,0.586004754408197
47,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,4,Up,0.0357038740002143,0.586004754408197
48,WP_BREAST_CANCER_PATHWAY,87,Up,0.0364455186165656,0.586004754408197
49,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Down,0.0369392455046503,0.586004754408197
50,WP_MONOAMINE_GPCRS,3,Down,0.0373128187665095,0.586004754408197
51,WP_PEPTIDE_GPCRS,13,Down,0.0374166149668995,0.586004754408197
52,WP_NRF2_PATHWAY,71,Up,0.0391699655036006,0.586004754408197
53,WP_RETINOBLASTOMA_GENE_IN_CANCER,68,Up,0.0395878409650588,0.586004754408197
54,WP_ANGIOGENESIS,13,Up,0.0396157858512362,0.586004754408197
55,WP_ENERGY_METABOLISM,41,Down,0.0403780836694393,0.586004754408197
56,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Down,0.0408966185173688,0.586004754408197
57,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Up,0.0411556613221146,0.586004754408197
58,WP_OXIDATIVE_DAMAGE_RESPONSE,32,Up,0.0413482673426708,0.586004754408197
59,WP_ALLOGRAFT_REJECTION,50,Up,0.0438327376065484,0.606113111983035
60,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,14,Down,0.0445457198043193,0.606113111983035
61,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,21,Up,0.0449791968746535,0.606113111983035
62,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Down,0.0478080476152386,0.633842179673002
63,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Down,0.0495072376578935,0.635975294534313
64,WP_IDO_METABOLIC_PATHWAY,7,Down,0.0502951591865984,0.635975294534313
65,WP_COPPER_HOMEOSTASIS,39,Up,0.0509477578134187,0.635975294534313
66,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.0510637097801273,0.635975294534313
67,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,15,Up,0.0527240312622106,0.646853040261748
68,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Up,0.0551702768493056,0.666911287796017
69,WP_CHOLESTASIS,9,Up,0.0567430057938973,0.670969116081743
70,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Up,0.0575046892964365,0.670969116081743
71,WP_PDGF_PATHWAY,36,Down,0.0619906113749212,0.670969116081743
72,WP_RANKLRANK_SIGNALING,47,Up,0.0622582534936228,0.670969116081743
73,WP_PPARALPHA_PATHWAY,15,Up,0.0623795479378032,0.670969116081743
74,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,32,Down,0.0625858110255405,0.670969116081743
75,WP_THERMOGENESIS,74,Down,0.062666019926706,0.670969116081743
76,WP_HUNGER_AND_SATIETY,2,Down,0.0635510513745328,0.670969116081743
77,WP_RETINOL_METABOLISM,6,Down,0.0636580904680537,0.670969116081743
78,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,71,Up,0.0636686022559318,0.670969116081743
79,WP_BENZOAPYRENE_METABOLISM,5,Up,0.064546546886983,0.671610905583545
80,WP_NUCLEOTIDE_GPCRS,5,Down,0.0664677502050852,0.680349668965037
81,WP_IL26_SIGNALING,31,Up,0.0670417557009343,0.680349668965037
82,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Up,0.0689449173303677,0.68385313539682
83,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Up,0.0690945257136544,0.68385313539682
84,WP_IL7_SIGNALING,23,Up,0.0698828021573393,0.68385313539682
85,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Down,0.0712637071915777,0.689161968370317
86,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,18,Up,0.0721467438045913,0.689588644271791
87,WP_SPINAL_CORD_INJURY,64,Up,0.073035351137909,0.690058145234037
88,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,3,Down,0.0767494633087735,0.716909759543316
89,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Up,0.080179918692035,0.740538125447784
90,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Down,0.0834113425403003,0.743866693479731
91,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Down,0.0854647955704224,0.743866693479731
92,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Down,0.0858305771843324,0.743866693479731
93,WP_MELANOMA,53,Up,0.0863867708855438,0.743866693479731
94,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,85,Up,0.0864942775610186,0.743866693479731
95,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Up,0.0868028955014219,0.743866693479731
96,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Down,0.0872056427278567,0.743866693479731
97,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Down,0.0886076010986011,0.743866693479731
98,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Up,0.0895419967529164,0.743866693479731
99,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,21,Up,0.0907471724639851,0.743866693479731
100,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Up,0.092288332225595,0.743866693479731
101,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Up,0.0923460523254834,0.743866693479731
102,WP_OSTEOCLAST_SIGNALING,9,Up,0.0926382411546391,0.743866693479731
103,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Down,0.0932095735138835,0.743866693479731
104,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Up,0.0945920157112066,0.747640739563575
105,WP_CCL18_SIGNALING,20,Up,0.0978941916728333,0.756484402943808
106,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Up,0.0981124105168928,0.756484402943808
107,WP_GPCRS_CLASS_A_RHODOPSINLIKE,40,Down,0.0984718140085006,0.756484402943808
108,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Down,0.099915457912291,0.760467651887993
109,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,50,Up,0.103630316435092,0.77493771745175
110,WP_P38_MAPK_SIGNALING,31,Down,0.103702127639529,0.77493771745175
111,WP_TRIACYLGLYCERIDE_SYNTHESIS,18,Down,0.10536918825016,0.780189020238007
112,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,7,Up,0.10725250393078,0.780189020238007
113,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Down,0.109595405094423,0.780189020238007
114,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Up,0.10967890910728,0.780189020238007
115,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,17,Up,0.109734291532994,0.780189020238007
116,WP_4P163_COPY_NUMBER_VARIATION,21,Down,0.110099667089548,0.780189020238007
117,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Up,0.114879149077227,0.807099662747695
118,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Down,0.116849336716798,0.807943405075896
119,WP_G13_SIGNALING,29,Down,0.117869769927365,0.807943405075896
120,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,37,Down,0.117947942346846,0.807943405075896
121,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,29,Up,0.122754372650702,0.818609008021982
122,WP_GLYCOSPHINGOLIPID_METABOLISM,12,Down,0.124075185507382,0.818609008021982
123,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Up,0.124088950247716,0.818609008021982
124,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Up,0.124131823283387,0.818609008021982
125,WP_SILDENAFIL_TREATMENT,10,Up,0.124484338202856,0.818609008021982
126,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,12,Up,0.125519620503162,0.818866095663487
127,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.128243796680212,0.821445553497102
128,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Down,0.128296840594167,0.821445553497102
129,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Down,0.128912988322538,0.821445553497102
130,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Down,0.131200617923387,0.826199444186595
131,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,17,Up,0.132112989435285,0.826199444186595
132,WP_CELL_DIFFERENTIATION_INDEX,7,Down,0.134035941694528,0.826199444186595
133,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,15,Down,0.134575270658437,0.826199444186595
134,WP_TROP2_REGULATORY_SIGNALING,42,Up,0.134684580925795,0.826199444186595
135,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,19,Down,0.136048666392464,0.827977987613098
136,WP_NUCLEAR_RECEPTORS_METAPATHWAY,175,Up,0.136989058777836,0.827977987613098
137,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Up,0.142953102472043,0.834242044908172
138,WP_HEME_BIOSYNTHESIS,8,Up,0.142953102472043,0.834242044908172
139,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Down,0.144003542450671,0.834242044908172
140,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Up,0.14475096383874,0.834242044908172
141,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,2,Down,0.14664145681203,0.834242044908172
142,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,131,Up,0.14784865674935,0.834242044908172
143,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,32,Up,0.148482915751075,0.834242044908172
144,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Down,0.148828052595857,0.834242044908172
145,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,40,Up,0.148885714098896,0.834242044908172
146,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Up,0.149510412588089,0.834242044908172
147,WP_ATR_SIGNALING,10,Up,0.151392290432101,0.834242044908172
148,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Down,0.152925884760747,0.834242044908172
149,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,2,Up,0.15482803058601,0.834242044908172
150,WP_TAMOXIFEN_METABOLISM,2,Up,0.155455357122987,0.834242044908172
151,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Down,0.155690530571283,0.834242044908172
152,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,23,Up,0.156049549445698,0.834242044908172
153,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,7,Up,0.157132876755845,0.834242044908172
154,WP_TP53_NETWORK,16,Up,0.157370235540329,0.834242044908172
155,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,9,Up,0.157807934151351,0.834242044908172
156,WP_KALLMANN_SYNDROME,11,Up,0.159473598584365,0.834242044908172
157,WP_BLOOD_CLOTTING_CASCADE,5,Down,0.159682630457539,0.834242044908172
158,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,61,Up,0.160353093790135,0.834242044908172
159,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Up,0.161796794532153,0.835304438812776
160,WP_15Q11Q13_COPY_NUMBER_VARIATION,33,Up,0.162589671788375,0.835304438812776
161,WP_TOLLLIKE_RECEPTOR_SIGNALING,79,Up,0.164069376933517,0.836406626390383
162,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,46,Down,0.167479186268333,0.836406626390383
163,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Down,0.169344366898444,0.836406626390383
164,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,3,Up,0.169684889610899,0.836406626390383
165,WP_UROTENSINIIMEDIATED_SIGNALING,48,Up,0.16979632533162,0.836406626390383
166,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,17,Up,0.171025882993461,0.836406626390383
167,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,10,Up,0.171710318168047,0.836406626390383
168,WP_HIPPOYAP_SIGNALING,16,Up,0.173623084891174,0.836406626390383
169,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,13,Down,0.175652848320553,0.836406626390383
170,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,73,Up,0.17654173873981,0.836406626390383
171,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,Up,0.177545789224638,0.836406626390383
172,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,27,Down,0.177649599811892,0.836406626390383
173,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,28,Down,0.178815640762813,0.836406626390383
174,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Down,0.17885296462424,0.836406626390383
175,WP_CANCER_PATHWAYS,302,Up,0.179607790466128,0.836406626390383
176,WP_NEURAL_CREST_DIFFERENTIATION,39,Up,0.180115342904664,0.836406626390383
177,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,76,Down,0.180749737387532,0.836406626390383
178,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,60,Up,0.181918252453959,0.836406626390383
179,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,10,Up,0.1831584225694,0.836406626390383
180,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Down,0.183443583042605,0.836406626390383
181,WP_TGFB_SMAD_SIGNALING,7,Down,0.185172864508628,0.836406626390383
182,WP_NGLYCAN_BIOSYNTHESIS,52,Down,0.185189788324878,0.836406626390383
183,WP_GASTRIC_CANCER_NETWORK_2,24,Up,0.188903629164942,0.848517940839247
184,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,2,Up,0.1910905585547,0.850533136251576
185,WP_PANCREATIC_CANCER_SUBTYPES,5,Down,0.19298388931966,0.850533136251576
186,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,25,Up,0.195181461242175,0.850533136251576
187,WP_IL18_SIGNALING,186,Up,0.195470123300591,0.850533136251576
188,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Up,0.196077228074575,0.850533136251576
189,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.196614763433924,0.850533136251576
190,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Up,0.196668792631622,0.850533136251576
191,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Down,0.198055898309184,0.850533136251576
192,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,3,Up,0.198664674160952,0.850533136251576
193,WP_ONECARBON_METABOLISM,22,Up,0.20175007449649,0.852002439102607
194,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Up,0.202337556654701,0.852002439102607
195,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,11,Down,0.202667436593066,0.852002439102607
196,WP_GLUTATHIONE_METABOLISM,10,Up,0.203153866258043,0.852002439102607
197,WP_ARYLAMINE_METABOLISM,1,Up,0.20806509154395,0.860874006472741
198,WP_10Q22Q23_COPY_NUMBER_VARIATION,27,Down,0.208344836297193,0.860874006472741
199,WP_MALE_INFERTILITY,66,Up,0.20894718269076,0.860874006472741
200,WP_DISORDERS_IN_KETOLYSIS,4,Down,0.20945839573546,0.860874006472741
201,WP_G1_TO_S_CELL_CYCLE_CONTROL,50,Up,0.214569880403736,0.873360597006847
202,WP_VITAMIN_B12_DISORDERS,9,Down,0.218697042057774,0.873360597006847
203,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Up,0.219880793255903,0.873360597006847
204,WP_RETT_SYNDROME,31,Down,0.220540230041879,0.873360597006847
205,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,11,Up,0.223687798803236,0.873360597006847
206,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Up,0.224911795756196,0.873360597006847
207,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Up,0.225493636754933,0.873360597006847
208,WP_FOXP3_IN_COVID19,9,Up,0.225734615102686,0.873360597006847
209,WP_ENDOMETRIAL_CANCER,49,Up,0.226672529549568,0.873360597006847
210,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Down,0.226806071343997,0.873360597006847
211,WP_PROTEASOME_DEGRADATION,57,Up,0.227259876704393,0.873360597006847
212,WP_APOPTOSIS_MODULATION_AND_SIGNALING,78,Up,0.228282661632211,0.873360597006847
213,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,65,Up,0.228347997272371,0.873360597006847
214,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Up,0.228720169471862,0.873360597006847
215,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Up,0.231671156961248,0.873360597006847
216,WP_PROSTAGLANDIN_SIGNALING,19,Down,0.231796506249757,0.873360597006847
217,WP_GLUCOCORTICOID_BIOSYNTHESIS,6,Up,0.234370623640951,0.873360597006847
218,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,170,Up,0.234636150970854,0.873360597006847
219,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,16,Up,0.237127101053544,0.873360597006847
220,WP_EBOLA_VIRUS_INFECTION_IN_HOST,105,Up,0.238205358396184,0.873360597006847
221,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,35,Up,0.239242883396211,0.873360597006847
222,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Down,0.240178701947843,0.873360597006847
223,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Down,0.240882008732072,0.873360597006847
224,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Down,0.241646983408371,0.873360597006847
225,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Up,0.242969960848287,0.873360597006847
226,WP_PYRIMIDINE_METABOLISM,71,Up,0.243131877633281,0.873360597006847
227,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,60,Up,0.244367650540673,0.873360597006847
228,WP_CIRCADIAN_RHYTHM_GENES,119,Up,0.245251274274018,0.873360597006847
229,WP_PROLACTIN_SIGNALING,69,Up,0.247547567940743,0.873360597006847
230,WP_BURN_WOUND_HEALING,57,Up,0.248464469216978,0.873360597006847
231,WP_POSTCOVID_NEUROINFLAMMATION,11,Down,0.249556874850235,0.873360597006847
232,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,9,Up,0.250785097251431,0.873360597006847
233,WP_APOPTOSIS,71,Up,0.251802800996297,0.873360597006847
234,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,7,Down,0.251823835143083,0.873360597006847
235,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,10,Down,0.25250177796268,0.873360597006847
236,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Up,0.252619246237067,0.873360597006847
237,WP_NRF2ARE_REGULATION,20,Up,0.252674391042662,0.873360597006847
238,WP_LUNG_FIBROSIS,32,Down,0.252934115445171,0.873360597006847
239,WP_MINERALOCORTICOID_BIOSYNTHESIS,5,Up,0.253933312268414,0.873360597006847
240,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Down,0.25606908591197,0.876838144997504
241,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,29,Up,0.258855319509718,0.876838144997504
242,WP_PTF1A_RELATED_REGULATORY_PATHWAY,6,Up,0.26057868337097,0.876838144997504
243,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,15,Up,0.261257750807325,0.876838144997504
244,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,9,Up,0.261293646277682,0.876838144997504
245,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,19,Up,0.261344702584414,0.876838144997504
246,WP_SMALL_LIGAND_GPCRS,7,Up,0.26322647535923,0.879159265887284
247,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,14,Down,0.265040172708408,0.879159265887284
248,WP_PILOCYTIC_ASTROCYTOMA,6,Down,0.265927788140298,0.879159265887284
249,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Up,0.266314668133739,0.879159265887284
250,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,20,Up,0.272224017579355,0.887830010870899
251,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,19,Up,0.272955218130176,0.887830010870899
252,WP_KREBS_CYCLE_DISORDERS,11,Down,0.273229793324022,0.887830010870899
253,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,37,Up,0.274686896086345,0.887830010870899
254,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,19,Down,0.274725375992425,0.887830010870899
255,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,13,Up,0.275421718700826,0.887830010870899
256,WP_SYNAPTIC_VESICLE_PATHWAY,21,Up,0.283848760908691,0.88877769543788
257,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,43,Up,0.285892638053067,0.88877769543788
258,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Up,0.2860856347739,0.88877769543788
259,WP_SPHINGOLIPID_PATHWAY,19,Down,0.286110472737525,0.88877769543788
260,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Down,0.286272255165042,0.88877769543788
261,WP_AUTOPHAGY,27,Down,0.286274995506907,0.88877769543788
262,WP_MESODERMAL_COMMITMENT_PATHWAY,76,Up,0.287624056928002,0.88877769543788
263,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,33,Up,0.288247867225526,0.88877769543788
264,WP_PI3KAKT_SIGNALING,176,Up,0.290541445976467,0.88877769543788
265,WP_CREATINE_PATHWAY,2,Down,0.291421025135287,0.88877769543788
266,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,36,Up,0.292922971217204,0.88877769543788
267,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,38,Up,0.293018560670745,0.88877769543788
268,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,8,Up,0.293201323332059,0.88877769543788
269,WP_ID_SIGNALING,12,Up,0.295879845362608,0.88877769543788
270,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Down,0.296001871299664,0.88877769543788
271,WP_VALPROIC_ACID_PATHWAY,9,Down,0.296778002122889,0.88877769543788
272,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,13,Up,0.297483496093984,0.88877769543788
273,WP_WNT_SIGNALING_WP428,58,Up,0.297930774261167,0.88877769543788
274,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,56,Up,0.298471745028092,0.88877769543788
275,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Down,0.29916708972527,0.88877769543788
276,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,63,Down,0.299256085400153,0.88877769543788
277,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,19,Down,0.299502946029553,0.88877769543788
278,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,40,Up,0.301782728118085,0.891909521115464
279,WP_NONSMALL_CELL_LUNG_CANCER,58,Up,0.303447514283501,0.891909521115464
280,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Up,0.30381346218045,0.891909521115464
281,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,39,Up,0.308519034488723,0.896842308583803
282,WP_NOTCH_SIGNALING_WP61,49,Up,0.308950751206755,0.896842308583803
283,WP_PREIMPLANTATION_EMBRYO,21,Up,0.308968990717108,0.896842308583803
284,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,12,Down,0.309857926566667,0.896842308583803
285,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,26,Up,0.312164400600175,0.900347850152085
286,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,12,Down,0.313503730345196,0.901049183020108
287,WP_CARDIAC_HYPERTROPHIC_RESPONSE,44,Up,0.314867765035326,0.901816386268424
288,WP_PPAR_SIGNALING,39,Up,0.316203979733133,0.90249885882165
289,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Up,0.31742175458057,0.902815200971753
290,WP_PRION_DISEASE_PATHWAY,28,Up,0.319977232353154,0.902815200971753
291,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,86,Up,0.320364454349655,0.902815200971753
292,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Down,0.320708076257606,0.902815200971753
293,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,24,Up,0.323769963922978,0.908323926091086
294,WP_TYPE_II_INTERFERON_SIGNALING,30,Up,0.325082190964333,0.908903268614563
295,WP_CELL_CYCLE,92,Up,0.328070427273236,0.912823254374428
296,WP_GABA_METABOLISM_AKA_GHB,4,Down,0.328705210820962,0.912823254374428
297,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Up,0.330381755047363,0.91323717773356
298,WP_PURINERGIC_SIGNALING,14,Down,0.333820262861063,0.91323717773356
299,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,13,Up,0.334140347787478,0.91323717773356
300,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Up,0.334828187403057,0.91323717773356
301,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Down,0.33525978519623,0.91323717773356
302,WP_IL3_SIGNALING,46,Down,0.335520228315736,0.91323717773356
303,WP_ESTROGEN_SIGNALING,21,Up,0.337886255948979,0.915051329109953
304,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Down,0.338757353974195,0.915051329109953
305,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Up,0.34114098220159,0.915051329109953
306,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,7,Up,0.34172568095182,0.915051329109953
307,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,51,Up,0.341752747003352,0.915051329109953
308,WP_ENDODERM_DIFFERENTIATION,81,Up,0.346036738795598,0.921186738932513
309,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,20,Down,0.347394902566245,0.921186738932513
310,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Down,0.348020561894436,0.921186738932513
311,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,32,Up,0.349130653256628,0.921186738932513
312,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,16,Up,0.351343276801286,0.921186738932513
313,WP_PROXIMAL_TUBULE_TRANSPORT,25,Down,0.351884191563347,0.921186738932513
314,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,15,Up,0.35188885161169,0.921186738932513
315,WP_15Q25_COPY_NUMBER_VARIATION,28,Down,0.354998483623691,0.925975016639821
316,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,20,Up,0.357981106928565,0.925975016639821
317,WP_FLUOROPYRIMIDINE_ACTIVITY,25,Up,0.358692221132917,0.925975016639821
318,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Down,0.358728182150911,0.925975016639821
319,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Down,0.360086533036508,0.925975016639821
320,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Up,0.361587704615479,0.925975016639821
321,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,14,Down,0.363098584200924,0.925975016639821
322,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,47,Up,0.363659192583794,0.925975016639821
323,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Down,0.363856362986207,0.925975016639821
324,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,45,Up,0.370083649381957,0.938683589025002
325,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Down,0.371670673338248,0.938683589025002
326,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Up,0.373330903671823,0.938683589025002
327,WP_INTERFERONMEDIATED_SIGNALING,15,Up,0.374260128319977,0.938683589025002
328,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,18,Up,0.374559874939417,0.938683589025002
329,WP_IL9_SIGNALING,15,Up,0.376284556923186,0.940139531279205
330,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Up,0.378278766183705,0.942258017584864
331,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Up,0.381056593414024,0.944265180804411
332,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,55,Up,0.382661241177893,0.944265180804411
333,WP_ASPIRIN_AND_MIRNAS,8,Down,0.384020952422591,0.944265180804411
334,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,11,Up,0.38614518625214,0.944265180804411
335,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,37,Up,0.386735432049618,0.944265180804411
336,WP_GASTRIC_CANCER_NETWORK_1,16,Up,0.387612478317765,0.944265180804411
337,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.391950128257321,0.944265180804411
338,WP_VITAMIN_D_METABOLISM,6,Down,0.391961716944697,0.944265180804411
339,WP_NUCLEAR_RECEPTORS,20,Down,0.393254111778456,0.944265180804411
340,WP_EICOSANOID_SYNTHESIS,13,Down,0.393369716438464,0.944265180804411
341,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,102,Down,0.394529133799838,0.944265180804411
342,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,27,Down,0.395437060433743,0.944265180804411
343,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,14,Up,0.395894308000153,0.944265180804411
344,WP_MEVALONATE_PATHWAY,7,Down,0.3958991596378,0.944265180804411
345,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,51,Up,0.396315678074844,0.944265180804411
346,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.398439811263427,0.94624686023109
347,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Down,0.402320346678859,0.94624686023109
348,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,46,Down,0.403553150110387,0.94624686023109
349,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Up,0.403693571039819,0.94624686023109
350,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Down,0.404658595618838,0.94624686023109
351,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Up,0.405117417889382,0.94624686023109
352,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Down,0.405205468128155,0.94624686023109
353,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,28,Down,0.408301182212431,0.948829249608176
354,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Up,0.40861989581666,0.948829249608176
355,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Down,0.410440099795141,0.950371160652411
356,WP_SULINDAC_METABOLIC_PATHWAY,2,Down,0.415975317944205,0.954764186341122
357,WP_GLIAL_CELL_DIFFERENTIATION,4,Down,0.419121181464147,0.954764186341122
358,WP_LEUKOTRIENE_METABOLIC_PATHWAY,8,Down,0.419705928132459,0.954764186341122
359,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Up,0.420418476090902,0.954764186341122
360,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Down,0.421535132224609,0.954764186341122
361,WP_HOMOLOGOUS_RECOMBINATION,11,Down,0.421666255561643,0.954764186341122
362,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,3,Up,0.422124231302541,0.954764186341122
363,WP_ERBB_SIGNALING,67,Up,0.422398175227811,0.954764186341122
364,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Down,0.422790953562249,0.954764186341122
365,WP_PLEURAL_MESOTHELIOMA,248,Up,0.424473261367806,0.955937043409142
366,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Down,0.427977440013667,0.959515661225073
367,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,11,Down,0.428396894975185,0.959515661225073
368,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Up,0.429752247890999,0.959935727626089
369,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Up,0.432715094641768,0.962879235567666
370,WP_KININKALLIKREIN_PATHWAY,2,Up,0.433412794598584,0.962879235567666
371,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,43,Up,0.434807449083669,0.963373916837672
372,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Down,0.442206508855213,0.971635829404336
373,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Up,0.442376272842344,0.971635829404336
374,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,19,Down,0.442534995686648,0.971635829404336
375,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Down,0.444549617801317,0.971635829404336
376,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,70,Down,0.445190749738829,0.971635829404336
377,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,7,Down,0.449097292246665,0.971635829404336
378,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,30,Down,0.452308149453461,0.971635829404336
379,WP_CYTOSINE_METHYLATION,7,Up,0.453208836547578,0.971635829404336
380,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.453631734322579,0.971635829404336
381,WP_BIOGENIC_AMINE_SYNTHESIS,1,Up,0.454468601710907,0.971635829404336
382,WP_NEUROTRANSMITTER_DISORDERS,1,Up,0.454468601710907,0.971635829404336
383,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,14,Down,0.454853593170392,0.971635829404336
384,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,10,Up,0.454984047293378,0.971635829404336
385,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,40,Down,0.460465537557788,0.971635829404336
386,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Down,0.460887786660998,0.971635829404336
387,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,69,Up,0.460943930076149,0.971635829404336
388,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,35,Down,0.461653605825842,0.971635829404336
389,WP_WNT_SIGNALING_AND_PLURIPOTENCY,59,Down,0.462367219347556,0.971635829404336
390,WP_TAR_SYNDROME,43,Down,0.462662152812691,0.971635829404336
391,WP_EPO_RECEPTOR_SIGNALING,23,Up,0.464349496440729,0.971635829404336
392,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,33,Up,0.467211883941213,0.971635829404336
393,WP_NEOVASCULARIZATION_PROCESSES,22,Up,0.468345306621349,0.971635829404336
394,WP_FRAGILE_X_SYNDROME,83,Down,0.468985915070779,0.971635829404336
395,WP_RALA_DOWNSTREAM_REGULATED_GENES,12,Down,0.470890298032119,0.971635829404336
396,WP_ECTODERM_DIFFERENTIATION,76,Up,0.471381136007922,0.971635829404336
397,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Down,0.472571435629021,0.971635829404336
398,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,12,Up,0.472628119940491,0.971635829404336
399,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,82,Up,0.472938701504084,0.971635829404336
400,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Up,0.47310393026919,0.971635829404336
401,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,13,Down,0.473997527483137,0.971635829404336
402,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,45,Down,0.478991580982998,0.977237519013717
403,WP_CANONICAL_NFKB_PATHWAY,8,Up,0.479380124954945,0.977237519013717
404,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Up,0.482626005035318,0.977237519013717
405,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Up,0.483338933621136,0.977237519013717
406,WP_NEPHROTIC_SYNDROME,27,Up,0.485491322636656,0.977237519013717
407,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,49,Up,0.488420270940821,0.977237519013717
408,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Up,0.488587318958634,0.977237519013717
409,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,10,Up,0.488625640758609,0.977237519013717
410,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,24,Up,0.488688072170943,0.977237519013717
411,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,22,Up,0.488842723540198,0.977237519013717
412,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,15,Up,0.489807612936316,0.977237519013717
413,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Down,0.491506507372166,0.978252661162035
414,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Down,0.493820558798933,0.979198532916536
415,WP_PDGFRBETA_PATHWAY,26,Down,0.496173974108371,0.979198532916536
416,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Down,0.497527654475045,0.979198532916536
417,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Down,0.497535491538502,0.979198532916536
418,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Down,0.497937940096243,0.979198532916536
419,WP_IL10_ANTIINFLAMMATORY_SIGNALING,10,Up,0.502687034356627,0.983893036364487
420,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,20,Down,0.502719069675285,0.983893036364487
421,WP_FOXA2_PATHWAY,9,Up,0.504513818896476,0.98395230206887
422,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Up,0.505143395952631,0.98395230206887
423,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Up,0.510347675472093,0.98592255889818
424,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,44,Up,0.510756676983338,0.98592255889818
425,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Up,0.517434434180523,0.98592255889818
426,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,14,Up,0.517635896490908,0.98592255889818
427,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,105,Up,0.51865029141012,0.98592255889818
428,WP_13Q1212_COPY_NUMBER_VARIATION,20,Down,0.519602308760205,0.98592255889818
429,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Down,0.520140446282947,0.98592255889818
430,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,16,Down,0.52047777951388,0.98592255889818
431,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Down,0.521265828619329,0.98592255889818
432,WP_NAD_METABOLISM,12,Down,0.522991966708304,0.98592255889818
433,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,113,Up,0.526419625819626,0.98592255889818
434,WP_JOUBERT_SYNDROME,71,Down,0.52648613651162,0.98592255889818
435,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,13,Up,0.526649872954432,0.98592255889818
436,WP_PROTEOGLYCAN_BIOSYNTHESIS,15,Down,0.527444814135396,0.98592255889818
437,WP_IL19_SIGNALING,20,Up,0.528753172384949,0.98592255889818
438,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,13,Up,0.528871412410845,0.98592255889818
439,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Up,0.530087598827012,0.98592255889818
440,WP_CELLULAR_PROTEOSTASIS,6,Up,0.532424253466236,0.98592255889818
441,WP_GLUCURONIDATION,7,Down,0.532718957800128,0.98592255889818
442,WP_OSTEOPONTIN_SIGNALING,11,Down,0.533064061236931,0.98592255889818
443,WP_PAFAH1B1_COPY_NUMBER_VARIATION,9,Down,0.533176223970997,0.98592255889818
444,WP_ETHER_LIPID_BIOSYNTHESIS,16,Down,0.534800649101,0.98592255889818
445,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Up,0.53561206845738,0.98592255889818
446,WP_7OXOC_AND_7BETAHC_PATHWAYS,17,Up,0.536173618624535,0.98592255889818
447,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,30,Up,0.538312938921564,0.98592255889818
448,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Down,0.538747220732118,0.98592255889818
449,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,12,Up,0.539448621341449,0.98592255889818
450,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,72,Down,0.540039156234205,0.98592255889818
451,WP_CHEMOKINE_SIGNALING,108,Down,0.540938046305449,0.98592255889818
452,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Up,0.543154181054013,0.987399757525614
453,WP_6Q16_COPY_NUMBER_VARIATION,5,Down,0.54423225832382,0.987399757525614
454,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Down,0.54587888427016,0.987399757525614
455,WP_NAD_BIOSYNTHETIC_PATHWAYS,19,Down,0.546883498668118,0.987399757525614
456,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Down,0.551520695713803,0.987399757525614
457,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Up,0.551844008760451,0.987399757525614
458,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Up,0.553812110560846,0.987399757525614
459,WP_MTHFR_DEFICIENCY,18,Up,0.556589366945025,0.987399757525614
460,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Down,0.557079928252595,0.987399757525614
461,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Up,0.557911001195193,0.987399757525614
462,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Up,0.560929015831072,0.987399757525614
463,WP_TCELL_RECEPTOR_SIGNALING,71,Down,0.561752117356502,0.987399757525614
464,WP_ALSTROM_SYNDROME,27,Up,0.562725276551314,0.987399757525614
465,WP_BASE_EXCISION_REPAIR,29,Up,0.562828673170308,0.987399757525614
466,WP_UREA_CYCLE_AND_RELATED_DISEASES,3,Up,0.56545381483812,0.987399757525614
467,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,165,Up,0.565930884881139,0.987399757525614
468,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,11,Up,0.566052089507284,0.987399757525614
469,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Up,0.568573815143029,0.987399757525614
470,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,11,Up,0.569102522206075,0.987399757525614
471,WP_NETRINUNC5B_SIGNALING,34,Up,0.569336315703799,0.987399757525614
472,WP_RAS_SIGNALING,114,Up,0.569491786945611,0.987399757525614
473,WP_CANNABINOID_RECEPTOR_SIGNALING,16,Down,0.572875561338768,0.987399757525614
474,WP_METABOLIC_EPILEPTIC_DISORDERS,57,Down,0.576011424723722,0.987399757525614
475,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Down,0.577656201706123,0.987399757525614
476,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,8,Down,0.577738856923461,0.987399757525614
477,WP_AGERAGE_PATHWAY,53,Up,0.582108053998957,0.987399757525614
478,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,29,Up,0.582232707986468,0.987399757525614
479,WP_GLIOBLASTOMA_SIGNALING,66,Up,0.58574868500225,0.987399757525614
480,WP_MITOCHONDRIAL_BETAOXIDATION,8,Down,0.589605678074964,0.987399757525614
481,WP_16P112_PROXIMAL_DELETION_SYNDROME,62,Down,0.590508415654297,0.987399757525614
482,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,41,Up,0.592629896603113,0.987399757525614
483,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,52,Up,0.593233786099554,0.987399757525614
484,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Up,0.593454549466778,0.987399757525614
485,WP_IL17_SIGNALING,25,Up,0.596148111269284,0.987399757525614
486,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,69,Down,0.597450970401897,0.987399757525614
487,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Down,0.59864239882095,0.987399757525614
488,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,51,Down,0.598779681622891,0.987399757525614
489,WP_GPCRS_CLASS_B_SECRETINLIKE,4,Up,0.600095543155366,0.987399757525614
490,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,62,Up,0.601202966556801,0.987399757525614
491,WP_INTEGRINMEDIATED_CELL_ADHESION,72,Down,0.601586672401291,0.987399757525614
492,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Down,0.60305928970301,0.987399757525614
493,WP_HEDGEHOG_SIGNALING_WP4249,24,Down,0.604463326252742,0.987399757525614
494,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Down,0.605423998715823,0.987399757525614
495,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,8,Up,0.605799268539707,0.987399757525614
496,WP_TRANSSULFURATION_PATHWAY,8,Up,0.607844137622396,0.987399757525614
497,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,32,Down,0.608228413681793,0.987399757525614
498,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,6,Down,0.608324869294932,0.987399757525614
499,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,50,Up,0.612719872745319,0.987399757525614
500,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,23,Down,0.616610734962541,0.987399757525614
501,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,48,Down,0.62170923533348,0.987399757525614
502,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,72,Up,0.623633749744655,0.987399757525614
503,WP_NEUROINFLAMMATION,10,Up,0.625064992363614,0.987399757525614
504,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,5,Down,0.625400647177711,0.987399757525614
505,WP_IL6_SIGNALING,38,Up,0.625455573714072,0.987399757525614
506,WP_DOPAMINERGIC_NEUROGENESIS,4,Down,0.625462026106385,0.987399757525614
507,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,11,Up,0.62666963811275,0.987399757525614
508,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,27,Down,0.626898227320819,0.987399757525614
509,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Down,0.627160329614158,0.987399757525614
510,WP_DRAVET_SYNDROME,13,Up,0.627518081714943,0.987399757525614
511,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Up,0.630803517522943,0.987399757525614
512,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,46,Up,0.631196278185957,0.987399757525614
513,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Down,0.63177913097675,0.987399757525614
514,WP_IRINOTECAN_PATHWAY,5,Up,0.631817949119323,0.987399757525614
515,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,34,Down,0.632843109032256,0.987399757525614
516,WP_INCLUSION_BODY_MYOSITIS,9,Up,0.632977124384308,0.987399757525614
517,WP_CILIOPATHIES,127,Down,0.635358945164685,0.987399757525614
518,WP_MRNA_PROCESSING,124,Down,0.63646256465836,0.987399757525614
519,WP_ADIPOGENESIS,86,Up,0.638403557648054,0.987399757525614
520,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,22,Up,0.638566699756127,0.987399757525614
521,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,76,Up,0.639350152459801,0.987399757525614
522,WP_NANOMATERIAL_INDUCED_APOPTOSIS,18,Up,0.64013476925786,0.987399757525614
523,WP_TRYPTOPHAN_METABOLISM,18,Down,0.64035634013633,0.987399757525614
524,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Down,0.641252634187619,0.987399757525614
525,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,4,Up,0.644653779503706,0.987399757525614
526,WP_GALANIN_RECEPTOR_PATHWAY,10,Up,0.645633373595992,0.987399757525614
527,WP_PURINE_METABOLISM,10,Up,0.647184221256398,0.987399757525614
528,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,46,Down,0.654410961079179,0.987399757525614
529,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Up,0.657422436719268,0.987399757525614
530,WP_HIPPO_SIGNALING_REGULATION,43,Down,0.6578897504818,0.987399757525614
531,WP_AXON_GUIDANCE,37,Up,0.657941038775206,0.987399757525614
532,WP_AFLATOXIN_B1_METABOLISM,2,Up,0.658286096062788,0.987399757525614
533,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,12,Down,0.658338226276536,0.987399757525614
534,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,38,Down,0.659235788014808,0.987399757525614
535,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,83,Down,0.660208535937487,0.987399757525614
536,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,16,Down,0.660474945298357,0.987399757525614
537,WP_OVARIAN_INFERTILITY,20,Up,0.660623947721638,0.987399757525614
538,WP_OSTEOBLAST_SIGNALING,3,Down,0.660795073621978,0.987399757525614
539,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Up,0.66675678566932,0.987399757525614
540,WP_IL2_SIGNALING,37,Up,0.667269491891738,0.987399757525614
541,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,23,Up,0.667869721484986,0.987399757525614
542,WP_16P112_DISTAL_DELETION_SYNDROME,20,Up,0.67063108873409,0.987399757525614
543,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,46,Down,0.670831939084979,0.987399757525614
544,WP_TARGET_OF_RAPAMYCIN_SIGNALING,32,Up,0.671300921301281,0.987399757525614
545,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Up,0.673300422994078,0.987399757525614
546,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,37,Up,0.675299818959894,0.987399757525614
547,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,60,Up,0.675891127064202,0.987399757525614
548,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,3,Down,0.677606013396764,0.987399757525614
549,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Up,0.67843298332108,0.987399757525614
550,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Up,0.67843298332108,0.987399757525614
551,WP_KCNQ2RELATED_EPILEPSIES,11,Down,0.679073262147301,0.987399757525614
552,WP_HYPERTROPHY_MODEL,13,Down,0.679779604571303,0.987399757525614
553,WP_TCELL_ACTIVATION_SARSCOV2,60,Up,0.679874636472288,0.987399757525614
554,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,30,Up,0.681538837733648,0.987399757525614
555,WP_CORI_CYCLE,11,Up,0.682364440218924,0.987399757525614
556,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Up,0.682815129147729,0.987399757525614
557,WP_BDNFTRKB_SIGNALING,26,Up,0.682945879505115,0.987399757525614
558,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,35,Down,0.683089023090976,0.987399757525614
559,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,21,Up,0.683558896481508,0.987399757525614
560,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Down,0.685986168023987,0.987399757525614
561,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,30,Down,0.691391389952727,0.987399757525614
562,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Down,0.69405543701153,0.987399757525614
563,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Up,0.694095898036844,0.987399757525614
564,WP_WHITE_FAT_CELL_DIFFERENTIATION,23,Up,0.694370402292473,0.987399757525614
565,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Up,0.694834914637317,0.987399757525614
566,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,79,Up,0.695101292822702,0.987399757525614
567,WP_TRANSLATION_FACTORS,49,Down,0.69515128389191,0.987399757525614
568,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Up,0.697465848374324,0.987399757525614
569,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Down,0.697839089737633,0.987399757525614
570,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,12,Down,0.698388028854987,0.987399757525614
571,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,56,Up,0.699515960515357,0.987399757525614
572,WP_REGULATION_OF_ACTIN_CYTOSKELETON,92,Down,0.700402579357552,0.987399757525614
573,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,54,Down,0.700748989481938,0.987399757525614
574,WP_FLUOROACETIC_ACID_TOXICITY,6,Down,0.703259086407615,0.987399757525614
575,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Down,0.705272041653652,0.987399757525614
576,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Down,0.705658487273976,0.987399757525614
577,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,28,Down,0.706399268059844,0.987399757525614
578,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,16,Up,0.707806369420552,0.987399757525614
579,WP_IL4_SIGNALING,50,Down,0.710258527343481,0.987399757525614
580,WP_ATM_SIGNALING,34,Up,0.710965284988936,0.987399757525614
581,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,15,Down,0.71229714242235,0.987399757525614
582,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Down,0.713045288533664,0.987399757525614
583,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,9,Down,0.713499145469742,0.987399757525614
584,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,9,Down,0.713499145469742,0.987399757525614
585,WP_MATRIX_METALLOPROTEINASES,8,Up,0.713827425709472,0.987399757525614
586,WP_MAPK_CASCADE,30,Down,0.714446320697273,0.987399757525614
587,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.716270342426666,0.987399757525614
588,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,88,Up,0.716361255111872,0.987399757525614
589,WP_PRIMARY_OVARIAN_INSUFFICIENCY,86,Down,0.71781256885003,0.987399757525614
590,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Up,0.720040878461235,0.987399757525614
591,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,6,Up,0.720861030539719,0.987399757525614
592,WP_NPHP1_DELETION_SYNDROME,10,Down,0.721454787782373,0.987399757525614
593,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Down,0.722373777436123,0.987399757525614
594,WP_GPR40_PATHWAY,7,Up,0.722573749200495,0.987399757525614
595,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,16,Up,0.723557946413365,0.987399757525614
596,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Up,0.723858600546415,0.987399757525614
597,WP_ENDOTHELIN_PATHWAYS,12,Up,0.724810242311685,0.987399757525614
598,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,34,Up,0.726094351066602,0.987399757525614
599,WP_UNFOLDED_PROTEIN_RESPONSE,24,Down,0.729119699370178,0.987399757525614
600,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Down,0.72936168933833,0.987399757525614
601,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,271,Up,0.729568045754536,0.987399757525614
602,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,13,Up,0.731833163831965,0.987399757525614
603,WP_RAC1PAK1P38MMP2_PATHWAY,51,Up,0.733380668628381,0.987399757525614
604,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,14,Down,0.734894771302123,0.987399757525614
605,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Down,0.735840412467593,0.987399757525614
606,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.736635679147152,0.987399757525614
607,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Down,0.738516297407529,0.987399757525614
608,WP_MAPK_SIGNALING,162,Up,0.738773113457529,0.987399757525614
609,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Down,0.740676918195824,0.987399757525614
610,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Up,0.741964814327429,0.987399757525614
611,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,47,Down,0.74489837001892,0.987399757525614
612,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,8,Down,0.745221772653526,0.987399757525614
613,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,47,Up,0.747769138517045,0.987399757525614
614,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,37,Up,0.747806469356244,0.987399757525614
615,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,60,Up,0.749470975226476,0.987399757525614
616,WP_OXIDATION_BY_CYTOCHROME_P450,14,Down,0.750117121009044,0.987399757525614
617,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,17,Down,0.75034122492025,0.987399757525614
618,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,89,Down,0.750471906695254,0.987399757525614
619,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Down,0.752070963984325,0.987399757525614
620,WP_5Q35_COPY_NUMBER_VARIATION,76,Up,0.75226137076274,0.987399757525614
621,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,25,Down,0.752785232573591,0.987399757525614
622,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Up,0.753712376642256,0.987399757525614
623,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Down,0.754892115448567,0.987399757525614
624,WP_B_CELL_RECEPTOR_SIGNALING,83,Down,0.755654551493363,0.987399757525614
625,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Up,0.757979641631346,0.987399757525614
626,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,43,Down,0.758120751369829,0.987399757525614
627,WP_THIAMINE_METABOLIC_PATHWAYS,9,Down,0.758181020145063,0.987399757525614
628,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,43,Up,0.758237533489009,0.987399757525614
629,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,9,Up,0.758969999664532,0.987399757525614
630,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,7,Up,0.762229940888786,0.987399757525614
631,WP_ESTROGEN_METABOLISM_WP5276,8,Up,0.762438218935694,0.987399757525614
632,WP_TNFALPHA_SIGNALING,82,Down,0.76301243627877,0.987399757525614
633,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Up,0.763446289363622,0.987399757525614
634,WP_SLEEP_REGULATION,11,Up,0.766842277654311,0.987399757525614
635,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,125,Up,0.767474266259693,0.987399757525614
636,WP_LEPTIN_AND_ADIPONECTIN,8,Up,0.767621450667342,0.987399757525614
637,WP_ACE_INHIBITOR_PATHWAY,5,Down,0.768643323682031,0.987399757525614
638,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Down,0.769016188261368,0.987399757525614
639,WP_AEROBIC_GLYCOLYSIS,10,Up,0.769895429042382,0.987399757525614
640,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,10,Up,0.769895429042382,0.987399757525614
641,WP_METHYLATION_PATHWAYS,5,Down,0.769979616269974,0.987399757525614
642,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Up,0.772832391287506,0.988042977125104
643,WP_INSULIN_SIGNALING,128,Down,0.773441597926353,0.988042977125104
644,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Down,0.774255463974075,0.988042977125104
645,WP_CILIARY_LANDSCAPE,184,Up,0.776340935516815,0.988042977125104
646,WP_FATTY_ACID_BETAOXIDATION,29,Down,0.776960733767644,0.988042977125104
647,WP_EFFECTS_OF_MFN2_MUTATION,17,Up,0.779806172842791,0.988042977125104
648,WP_ONCOSTATIN_M_SIGNALING,53,Up,0.783648505511505,0.988042977125104
649,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Up,0.783953700708278,0.988042977125104
650,WP_MELATONIN_METABOLISM_AND_EFFECTS,19,Up,0.784538510148444,0.988042977125104
651,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,39,Up,0.784695589797492,0.988042977125104
652,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,85,Up,0.786658310214305,0.988042977125104
653,WP_FATTY_ACID_OMEGAOXIDATION,2,Up,0.787150987674574,0.988042977125104
654,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Down,0.7894918486428,0.988042977125104
655,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Down,0.790323508701074,0.988042977125104
656,WP_MIRNA_BIOGENESIS,6,Down,0.792505978216503,0.988042977125104
657,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,19,Up,0.793081923744638,0.988042977125104
658,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Up,0.793465404530633,0.988042977125104
659,WP_ALPHA_6_BETA_4_SIGNALING,25,Up,0.793727733274469,0.988042977125104
660,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Down,0.796788642563451,0.988042977125104
661,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Down,0.797038592259038,0.988042977125104
662,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Down,0.79754273257172,0.988042977125104
663,WP_DNA_MISMATCH_REPAIR,21,Down,0.798899972759593,0.988042977125104
664,WP_COMPLEMENT_SYSTEM,49,Up,0.799614478098183,0.988042977125104
665,WP_DNA_REPLICATION,35,Up,0.800308439828174,0.988042977125104
666,WP_NOTCH_SIGNALING_WP268,35,Up,0.800589072657248,0.988042977125104
667,WP_CAMKK2_PATHWAY,29,Up,0.802797549362755,0.988042977125104
668,WP_NONHOMOLOGOUS_END_JOINING,10,Down,0.803871434936046,0.988042977125104
669,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,40,Up,0.805163834621211,0.988042977125104
670,WP_NRXN1_DELETION_SYNDROME,2,Up,0.805339166269853,0.988042977125104
671,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,32,Down,0.80791685549091,0.988205874417217
672,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Up,0.808530579581703,0.988205874417217
673,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,27,Down,0.809078532217502,0.988205874417217
674,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,54,Down,0.813004807627114,0.989573985262826
675,WP_GLYCOLYSIS_IN_SENESCENCE,11,Up,0.8133187696238,0.989573985262826
676,WP_HISTONE_MODIFICATIONS,37,Up,0.814744402013399,0.989573985262826
677,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,17,Down,0.815108278524274,0.989573985262826
678,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Up,0.817546174365502,0.989573985262826
679,WP_OREXIN_RECEPTOR_PATHWAY,116,Down,0.818677454743986,0.989573985262826
680,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,13,Down,0.822238858420835,0.989573985262826
681,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Down,0.823425452941846,0.989573985262826
682,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Up,0.823610752210946,0.989573985262826
683,WP_ACUTE_MYELOID_LEUKEMIA,55,Up,0.824811894716096,0.989573985262826
684,WP_FATTY_ACID_BIOSYNTHESIS,21,Up,0.82526270013292,0.989573985262826
685,WP_MONOAMINE_TRANSPORT,12,Down,0.826058490957661,0.989573985262826
686,WP_SEROTONIN_AND_ANXIETY,6,Up,0.827334148427097,0.989573985262826
687,WP_TGFBETA_RECEPTOR_SIGNALING,35,Down,0.827401120549064,0.989573985262826
688,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Up,0.828256571606842,0.989573985262826
689,WP_G_PROTEIN_SIGNALING,61,Down,0.829589657648111,0.989728154697747
690,WP_TYPE_II_DIABETES_MELLITUS,14,Down,0.832962059755545,0.992311323360953
691,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Up,0.837454984228433,0.995733842115551
692,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Down,0.838852512373606,0.995733842115551
693,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,16,Up,0.839672873051861,0.995733842115551
694,WP_IL1_SIGNALING,51,Down,0.84068039711459,0.995733842115551
695,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,23,Down,0.844540226551744,0.995745081368584
696,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Down,0.844567351704165,0.995745081368584
697,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,12,Up,0.85019014454922,0.995745081368584
698,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,5,Up,0.854275670832014,0.995745081368584
699,WP_TYPE_III_INTERFERON_SIGNALING,7,Down,0.854567020902288,0.995745081368584
700,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,2,Down,0.854592310151302,0.995745081368584
701,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Up,0.855058908477497,0.995745081368584
702,WP_KIT_RECEPTOR_SIGNALING,49,Down,0.855285077107963,0.995745081368584
703,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Up,0.856284598204193,0.995745081368584
704,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Down,0.856879463043685,0.995745081368584
705,WP_GASTRIN_SIGNALING,92,Down,0.862257568998618,0.995745081368584
706,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,25,Up,0.862394729460296,0.995745081368584
707,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,13,Down,0.863858774011002,0.995745081368584
708,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Up,0.864783778854129,0.995745081368584
709,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Down,0.865417970722401,0.995745081368584
710,WP_MACROPHAGE_MARKERS,8,Down,0.865626147680283,0.995745081368584
711,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Up,0.867636528692329,0.995745081368584
712,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Down,0.868391323446646,0.995745081368584
713,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Down,0.868693730469516,0.995745081368584
714,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,63,Down,0.868821433913963,0.995745081368584
715,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Up,0.870136130364455,0.995745081368584
716,WP_MICROTUBULE_CYTOSKELETON_REGULATION,35,Down,0.871418776560426,0.995745081368584
717,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Down,0.874611136037658,0.995745081368584
718,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Up,0.875367247501759,0.995745081368584
719,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Down,0.875444859683801,0.995745081368584
720,WP_KLEEFSTRA_SYNDROME,25,Down,0.879705726400089,0.995745081368584
721,WP_SERINE_METABOLISM,5,Up,0.87984342352871,0.995745081368584
722,WP_BLADDER_CANCER,29,Up,0.880316131873073,0.995745081368584
723,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Down,0.883897067994328,0.995745081368584
724,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Up,0.885460369854861,0.995745081368584
725,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,55,Up,0.886549908338528,0.995745081368584
726,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Up,0.888131050753166,0.995745081368584
727,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,4,Up,0.88956196463202,0.995745081368584
728,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Up,0.893196530128594,0.995745081368584
729,WP_CHOLESTEROL_METABOLISM,53,Down,0.893865272492149,0.995745081368584
730,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Down,0.894924098359251,0.995745081368584
731,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Down,0.896301288295664,0.995745081368584
732,WP_EGFEGFR_SIGNALING,136,Down,0.896372839338183,0.995745081368584
733,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Up,0.896679846259918,0.995745081368584
734,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,21,Down,0.896693663235642,0.995745081368584
735,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.898065808112427,0.995745081368584
736,WP_ANDROGEN_RECEPTOR_SIGNALING,77,Down,0.898443180808293,0.995745081368584
737,WP_LIPID_PARTICLES_COMPOSITION,5,Up,0.901415254477123,0.995745081368584
738,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Down,0.901618963100517,0.995745081368584
739,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,37,Up,0.901686527332633,0.995745081368584
740,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Down,0.902955308274535,0.995745081368584
741,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,47,Up,0.903386994521425,0.995745081368584
742,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,23,Up,0.904608921238884,0.995745081368584
743,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,46,Down,0.904877946883606,0.995745081368584
744,WP_LIPID_METABOLISM_PATHWAY,23,Down,0.905237945765933,0.995745081368584
745,WP_OMEGA9_FATTY_ACID_SYNTHESIS,11,Down,0.906671433839618,0.995745081368584
746,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Down,0.907588118132389,0.995745081368584
747,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Up,0.908213601216105,0.995745081368584
748,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,29,Down,0.908288185358864,0.995745081368584
749,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,27,Down,0.909548731499586,0.995745081368584
750,WP_WNT_SIGNALING_WP363,36,Down,0.90968004471331,0.995745081368584
751,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,18,Down,0.912780948677421,0.995745081368584
752,WP_CALORIC_RESTRICTION_AND_AGING,7,Up,0.915223385958817,0.995745081368584
753,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,62,Up,0.915644972284184,0.995745081368584
754,WP_LEPTIN_SIGNALING,69,Down,0.915646601392698,0.995745081368584
755,WP_HEPATITIS_B_INFECTION,115,Up,0.916010639952043,0.995745081368584
756,WP_ACUTE_VIRAL_MYOCARDITIS,64,Down,0.916934581133579,0.995745081368584
757,WP_VEGFAVEGFR2_SIGNALING,334,Down,0.917006115080314,0.995745081368584
758,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,9,Up,0.921575319672208,0.997892141227953
759,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Up,0.921721757114156,0.997892141227953
760,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,23,Up,0.922625337388375,0.997892141227953
761,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Down,0.925778438263351,0.998659101309391
762,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,9,Up,0.927264790534256,0.998659101309391
763,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,26,Up,0.928852826797006,0.998659101309391
764,WP_CYTOSOLIC_DNASENSING_PATHWAY,53,Down,0.93180935702462,0.998659101309391
765,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,26,Down,0.935352612147204,0.998659101309391
766,WP_PHOSPHOINOSITIDES_METABOLISM,38,Up,0.935362280235653,0.998659101309391
767,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,6,Up,0.937084904799347,0.998659101309391
768,WP_VITAMIN_D_RECEPTOR_PATHWAY,81,Down,0.938587231464378,0.998659101309391
769,WP_OPIOID_RECEPTOR_PATHWAYS,25,Up,0.938867932225248,0.998659101309391
770,WP_LUNG_PATHOLOGY_OF_COVID19,13,Down,0.939483410001641,0.998659101309391
771,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,37,Down,0.940664539518386,0.998659101309391
772,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,57,Up,0.944180338847331,0.998659101309391
773,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Up,0.946446861905628,0.998659101309391
774,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,3,Up,0.94658609007184,0.998659101309391
775,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Down,0.949469844697752,0.998659101309391
776,WP_HEART_DEVELOPMENT,16,Up,0.95011177516968,0.998659101309391
777,WP_METASTATIC_BRAIN_TUMOR,5,Up,0.952082230930557,0.998659101309391
778,WP_FOCAL_ADHESION,117,Down,0.95257054342801,0.998659101309391
779,WP_AMINO_ACID_METABOLISM,59,Down,0.95418486874401,0.998659101309391
780,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Up,0.95639075466748,0.998659101309391
781,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Down,0.957088841095615,0.998659101309391
782,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Up,0.957777060843784,0.998659101309391
783,WP_TCA_CYCLE_IN_SENESCENCE,10,Up,0.95791246008455,0.998659101309391
784,WP_IL5_SIGNALING,37,Down,0.959166578809307,0.998659101309391
785,WP_BARDETBIEDL_SYNDROME,65,Down,0.960043895303585,0.998659101309391
786,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,24,Up,0.960060498865366,0.998659101309391
787,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,42,Up,0.961391241548299,0.998659101309391
788,WP_PARKINSONS_DISEASE_PATHWAY,26,Down,0.962217475827685,0.998659101309391
789,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Down,0.962306507590194,0.998659101309391
790,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Down,0.965877543525424,0.998659101309391
791,WP_COMPLEMENT_AND_COAGULATION_CASCADES,23,Up,0.966326777662794,0.998659101309391
792,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,23,Up,0.966326777662794,0.998659101309391
793,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Up,0.970074854732287,0.998659101309391
794,WP_STEROID_BIOSYNTHESIS,2,Down,0.970593687555525,0.998659101309391
795,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,4,Down,0.972282816587761,0.998659101309391
796,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Up,0.972300113790895,0.998659101309391
797,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Down,0.972618421112714,0.998659101309391
798,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,9,Down,0.973435743393732,0.998659101309391
799,WP_ALZHEIMERS_DISEASE,183,Up,0.974104753583207,0.998659101309391
800,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,183,Up,0.974104753583207,0.998659101309391
801,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,19,Down,0.974787956922818,0.998659101309391
802,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Down,0.977030559479359,0.998659101309391
803,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,21,Down,0.977806919913279,0.998659101309391
804,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,30,Up,0.978768248680875,0.998659101309391
805,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,13,Up,0.981689536925857,0.998659101309391
806,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,19,Down,0.983786058106855,0.998659101309391
807,WP_ENDOCHONDRAL_OSSIFICATION,26,Up,0.98461040901033,0.998659101309391
808,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,26,Up,0.98461040901033,0.998659101309391
809,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,14,Down,0.985454902765161,0.998659101309391
810,WP_SPINA_BIFIDA,10,Up,0.987379986772512,0.998659101309391
811,WP_GLYOXYLATE_METABOLISM,5,Down,0.988103831686603,0.998659101309391
812,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,6,Down,0.989238939016787,0.998659101309391
813,WP_ULCERATIVE_COLITIS_SIGNALING,12,Down,0.991039426306885,0.998659101309391
814,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,90,Up,0.991265204831896,0.998659101309391
815,WP_KETOGENESIS_AND_KETOLYSIS,6,Up,0.991925680805903,0.998659101309391
816,WP_IL11_SIGNALING,40,Up,0.992969721687469,0.998659101309391
817,WP_MEASLES_VIRUS_INFECTION,99,Up,0.993079033702241,0.998659101309391
818,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,19,Up,0.993799446315185,0.998659101309391
819,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Down,0.996854704100318,0.999899576207713
820,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,11,Down,0.998981753451417,0.999899576207713
821,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,7,Up,0.999832006967674,0.999899576207713
822,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,35,Up,0.999899576207713,0.999899576207713
